Cite
HARVARD Citation
Pritchard, C. et al. (2013). AB0302 Results from the rate-ra study: a multicenter, open-label, single-arm study to evaluate the safety of administering rituximab at a more rapid infusion rate in patients with rheumatoid arthritis. Annals of the rheumatic diseases. p. A879. [Online].